Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

IFI16-dependent STING signaling is a crucial regulator of anti-HER2 immune response in HER2+ breast cancer
L.S. Ong, Wee Chyan Lee, Shijun Ma, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 31
Open Access | Times Cited: 543

Showing 1-25 of 543 citing articles:

Harnessing innate immune pathways for therapeutic advancement in cancer
An-Kang Hu, Li Sun, Hao Lin, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 54
Cellular senescence-associated gene IFI16 promotes HMOX1-dependent evasion of ferroptosis and radioresistance in glioblastoma
Yuchuan Zhou, Liang Zeng, Linbo Cai, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 2
New genetic and epigenetic insights into the chemokine system: the latest discoveries aiding progression toward precision medicine
Hanli Xu, Shuye Lin, Ziyun Zhou, et al.
Cellular and Molecular Immunology (2023) Vol. 20, Iss. 7, pp. 739-776
Open Access | Times Cited: 32
Intimate communications within the tumor microenvironment: stromal factors function as an orchestra
Bing Cheng, Qiang Yu, Wenyu Wang
Journal of Biomedical Science (2023) Vol. 30, Iss. 1
Open Access | Times Cited: 25
Epigenetic modulations in triple-negative breast cancer: Therapeutic implications for tumor microenvironment
Linlin Zhou, Danny Yu
Pharmacological Research (2024) Vol. 204, pp. 107205-107205
Open Access | Times Cited: 15
Epigenetic modulation of antitumor immunity and immunotherapy response in breast cancer: biological mechanisms and clinical implications
Jun Yin, Tiezheng Gu, Norin Chaudhry, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 11
EZH2: The roles in targeted therapy and mechanisms of resistance in breast cancer
Y. Chen, Hongyan Zhu, Yi Luo, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 175, pp. 116624-116624
Open Access | Times Cited: 8
Targeting P4HA1 promotes CD8+ T cell progenitor expansion toward immune memory and systemic anti-tumor immunity
Shijun Ma, L.S. Ong, Zemin Jiang, et al.
Cancer Cell (2024)
Closed Access | Times Cited: 7
Targeting undruggable phosphatase overcomes trastuzumab resistance by inhibiting multi-oncogenic kinases
Lu Wang, Yu‐Sheng Lin, Zhimeng Yao, et al.
Drug Resistance Updates (2024) Vol. 76, pp. 101118-101118
Open Access | Times Cited: 4
The Role of CXCL11 and its Receptors in Cancer: Prospective but Challenging Clinical Targets
Jiaqi Wang, Xinting Ouyang, Weijian Zhu, et al.
Cancer Control (2024) Vol. 31
Open Access | Times Cited: 3
MRAS: Master Regulator Analysis of Alternative Splicing
Lei Zhou, Yue Huang, Yang Zhao, et al.
Advanced Science (2025)
Open Access
A novel 4-1BB/HER2 bispecific antibody shows potent antitumor activities by increasing and activating tumor-infiltrating T cells.
Aolin Shen, Wenting Liu, Huizhen Wang, et al.
PubMed (2023) Vol. 13, Iss. 7, pp. 3246-3256
Closed Access | Times Cited: 7
Integrative transcriptomic and genomic analyses unveil the IFI16 variants and expression as MASLD progression markers
Do Yoon Kim, Masaud Shah, Jang Hyun Kim, et al.
Hepatology (2024)
Closed Access | Times Cited: 2
Multifaceted roles of cGAS-STING pathway in the lung cancer: from mechanisms to translation
Mingming Wei, Qingzhou Li, Shengrong Li, et al.
PeerJ (2024) Vol. 12, pp. e18559-e18559
Open Access | Times Cited: 2
Development of a risk model to predict prognosis in breast cancer based on cGAS-STING-related genes
Chen Chen, Junxiao Wang, Chao Dong, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 5
Phosphorylation of EZH2 differs HER2-positive breast cancer invasiveness in a site-specific manner
Yu Feng, Lili Li, Mengwen Zhang, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 4
Hypoxia makes EZH2 inhibitor not easy—advances of crosstalk between HIF and EZH2
Z. Huang, Yuanjun Tang, Jianlin Zhang, et al.
Life Metabolism (2024) Vol. 3, Iss. 4
Open Access | Times Cited: 1
A High Immune-Related Index with the Suppression of cGAS-STING Pathway is a Key Determinant to Herceptin Resistance in HER2+ Breast Cancer
Ruizhao Cai, Qingshan Chen, Dechang Zhao, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 9, pp. 3497-3514
Open Access | Times Cited: 1
Bidirectional regulation of the cGAS-STING pathway in the immunosuppressive tumor microenvironment and its association with immunotherapy
Yurui Zhang, Yudi Wang, Peizheng Mu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Dual mode of IFI16 binding to supercoiled and linear DNA: A closer insight
Natália Valková, Libuše Kratochvilová, Lucia Hároníková, et al.
Biochemical and Biophysical Research Communications (2023) Vol. 667, pp. 89-94
Closed Access | Times Cited: 3
BTLA is differentially expressed in central nervous system metastasis.
Shahan Mamoor
(2023)
Open Access | Times Cited: 3
At the Crossroads of the cGAS-cGAMP-STING Pathway and the DNA Damage Response: Implications for Cancer Progression and Treatment
Tatyana V. Korneenko, Nikolay B. Pestov, Ivan Nevzorov, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 12, pp. 1675-1675
Open Access | Times Cited: 3
Role of STING protein in breast cancer: mechanisms and therapeutic implications
Yue Jiang, Juliang Zhang
Medical Oncology (2022) Vol. 40, Iss. 1
Closed Access | Times Cited: 5
Survival is associated with repressive histone trimethylation markers in both HR-positive HER2-negative and triple-negative breast cancer patients
Bo Wang, Meng Zhou, Yue-Yu Shi, et al.
Virchows Archiv (2023) Vol. 482, Iss. 6, pp. 1047-1056
Closed Access | Times Cited: 2
ICOS is differentially expressed in central nervous system metastasis.
Shahan Mamoor
(2023)
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top